caffeic acid phenethyl ester has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, XX; Gonzalez, FJ; Krausz, KW; Liu, YM; Niu, B; Xie, C; Zhong, XC | 1 |
| Hong, MJ; Hur, HJ; Kim, MS; Kim, SH; Kwon, DY; Park, HS | 1 |
2 other study(ies) available for caffeic acid phenethyl ester and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity.
Topics: Animals; Bacteria; Bile Acids and Salts; Ceramides; Intestines; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Propolis | 2023 |
Caffeic Acid Phenethyl Ester Improves Metabolic Syndrome by Activating PPAR-γ and Inducing Adipose Tissue Remodeling in Diet-Induced Obese Mice.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Caffeic Acids; Diet, High-Fat; Hyperlipidemias; Insulin Resistance; Male; Metabolic Syndrome; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Panniculitis; Phenylethyl Alcohol; PPAR gamma | 2018 |